Fresenius starts $250M U.S. site expansion

SourceFierce Pharma
Date Published09/22/2017
Author NameEric Palmer
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Fresenius Kabi
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Foreign Direct Investment
Year reshoring announced:2016
Year reshoring implemented or to be implemented:2026
Capital investment ($):250
Country(ies) from which reshored:Germany
City reshored to:Melrose Park
State(s) reshored to:IL
If relevant, work nearshored to:-
Industry(ies):Medical Equipment & Supplies
Product(s) reshoredSterile Injectables
What domestic positive factors made reshoring more attractive?Government Incentives
Find Reshoring Articles